Dr. Benjamin Garmezy, a GU medical oncologist at SCRI Oncology Partners and Associate Director of GU Cancer Research at Sarah Cannon Research Institute, shares essential insights into prostate cancer—from early detection and risk factors to the latest in treatment innovations.
Learn why early screening matters, how family history plays a role, and what new therapies are offering hope for long-term remission.
#ProstateCancerAwareness #SCRIOncology #CancerResearch #MensHealth
Learn why early screening matters, how family history plays a role, and what new therapies are offering hope for long-term remission.
#ProstateCancerAwareness #SCRIOncology #CancerResearch #MensHealth
- Categoria
- Oncology
Commenta per primo questo video.









